Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer

Oncogene

Volumn 35, Issue 2, 2016, Pages 187-195

  Yu, J ^a   Wu, W K K ^a,b   Liang, Q ^a   Zhang, N ^a,c   He, J ^a   Li, X ^a   Zhang, X ^a   Xu, L ^a   Chan, M T V ^b   Ng, S S M ^b   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CHIMERIC PROTEIN; DNA; RNA; TRANSCRIPTOME; BETA LACTAMASE; LACTB2 PROTEIN, HUMAN; NCOA2 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOPROTEIN;

ARTICLE; CHROMOSOME TRANSLOCATION; COLORECTAL CANCER; DNA STRUCTURE; DOWN REGULATION; FUSION GENE; GENE DISRUPTION; GENE FUNCTION; GENE REARRANGEMENT; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; GENOMIC FRAGMENT; HUMAN; LACTB2 NCOA2 FUSION GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; UPREGULATION; WILD TYPE; WNT SIGNALING PATHWAY; AGED; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

AGED; ANIMALS; BETA CATENIN; BETA-LACTAMASES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE REARRANGEMENT; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE, INBRED BALB C; NUCLEAR RECEPTOR COACTIVATOR 2; ONCOGENE PROTEINS, FUSION; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84954375849     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.72     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Wong SH, Sung JJ, Chan FK, To KF, Ng SS, Wang XJ et al. Genome-wide association and sequencing studies on colorectal cancer. Semin Cancer Biol 2013; 23:502-511.
3. Wu WK, Wang XJ, Cheng AS, Luo MX, Ng SS, To KF et al. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol 2013; 86: 251-277.
4. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.
5. Yu J,Wu WK, Li X, He J, Li XX,Ng SS et al. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut 2014, pii: gutjnl-2013-306620.
6. Bunting SF, Nussenzweig A. End-joining, translocations and cancer. Nat Rev Cancer 2013; 13: 443-454.
7. Annala MJ, Parker BC, Zhang W, Nykter M. Fusion genes and their discovery using high throughput sequencing. Cancer Lett 2013; 340: 192-200.
8. Guo G, Sun X, Chen C, Wu S, Huang P, Li Z et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 2013; 45: 1459-1463.
9. Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P et al. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest 2013; 123: 855-865.
10. Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM. Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr 2008; 2008: 25-31.
11. Quintas-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 2009; 113: 1619-1630.
12. Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al. Recurrent R-spondin fusions in colon cancer. Nature 2012; 488: 660-664.
13. Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012; 18: 382-384.
14. Bass AJ, Lawrence MS, Brace LE, Ramos AH, Drier Y, Cibulskis K et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A- TCF7L2 fusion. Nat Genet 2011; 43: 964-968.
15. Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S et al. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 1999; 19: 1049-1055.
16. Hong H, Kohli K, Garabedian MJ, Stallcup MR. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 1997; 17: 2735-2744.
17. Aguilera O, Pena C, Garcia JM, Larriba MJ, Ordonez-Moran P, Navarro D et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007; 28: 1877-1884.
18. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005; 26: 898-915.
19. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin- LEF/TCF and retinoid signaling pathways. Curr Biol 1999; 9: 1415-1418.
20. Kefalopoulou Z, Tzelepi V, Zolota V, Grivas PD, Christopoulos C, Kalofonos H et al. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol 2012; 106: 23-31.
21. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
22. Malkova A, Ira G. Break-induced replication: functions and molecular mechanism. Curr Opin Genet Dev 2013; 23: 271-279.
23. Maher CA, Wilson RK. Chromothripsis and human disease: piecing together the shattering process. Cell 2012; 148: 29-32.
24. Walfish PG, Yoganathan T, Yang YF, Hong H, Butt TR, Stallcup MR. Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci USA 1997; 94: 3697-3702.
25. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996; 15: 3667-3675.
26. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 1996; 93: 4948-4952.
27. D'Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci 2008; 65: 1523-1543.
28. Gingeras TR. Implications of chimaeric non-co-linear transcripts. Nature 2009; 461: 206-211.
29. Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R et al. Transcription-mediated gene fusion in the human genome. Genome Res 2006; 16: 30-36.
30. Herai RH, Yamagishi ME. Detection of human interchromosomal trans-splicing in sequence databanks. Brief Bioinform 2010; 11: 198-209.
31. Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 2009; 106: 12353-12358.
32. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J et al. Prognostic values of microRNAs in colorectal cancer. Biomarker Insights 2006; 2: 113-121.
33. Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S et al. Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Lett 2013; 329: 155-163.
34. Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ. CpG islands recruit a histone H3 lysine 36 demethylase. Mol Cell 2010; 38: 179-190.
35. Frenkel-Morgenstern M, Lacroix V, Ezkurdia I, Levin Y, Gabashvili A, Prilusky J et al. Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts. Genome Res 2012; 22: 1231-1242.
36. Nothwang HG, Kim HG, Aoki J, Geisterfer M, Kubart S, Wegner RD et al. Functional hemizygosity of PAFAH1B3 due to a PAFAH1B3-CLK2 fusion gene in a female with mental retardation, ataxia and atrophy of the brain. Hum Mol Genet 2001; 10: 797-806.
37. Yoshida H, Miyachi M, Sakamoto K, Ouchi K, Yagyu S, Kikuchi K et al. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells. Oncogene 2014; 33: 5601-5608.
38. Nakayama R, Miura Y, Ogino J, Susa M, Watanabe I, Horiuchi K et al. Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma. Pathol Int 2012; 62: 823-826.
39. Arbajian E, Magnusson L, Mertens F, Domanski HA, Vult von Steyern F, Nord KH. A novel GTF2I/NCOA2 fusion gene emphasizes the role of NCOA2 in soft tissue angiofibroma development. Genes Chromosomes Cancer 2013; 52: 330-331.
40. Strehl S, Nebral K, Konig M, Harbott J, Strobl H, Ratei R et al. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res 2008; 14: 977-983.
41. Liang J, Prouty L, Williams BJ, Dayton MA, Blanchard KL. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 1998; 92: 2118-2122.
42. Carapeti M, Aguiar RC, Goldman JM, Cross NC. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 1998; 91: 3127-3133.